http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107072970-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C335-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17
filingDate 2015-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adcfbbaed2551695cb96125e20cc5292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56d5aeed40ae17cf5a223bda4efc0f67
publicationDate 2017-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107072970-A
titleOfInvention Novel capsaicin analogs for the treatment of cancer and other proliferative diseases
abstract The present disclosure generally relates to capsaipine derivatives and methods of their use. In some aspects, the present disclosure relates to the use of capsaipine derivatives to treat cancer or other hyperproliferative diseases. In some aspects of the present disclosure, the present disclosure provides capsaipine derivatives useful in the treatment of cancer. Such cancers for which the compounds are useful for treatment include, but are not limited to, breast cancer, cervical cancer, oral cancer, head cancer, neck cancer or prostate cancer. In some aspects, the compounds may be used to treat tumors by injecting the compounds directly into tumors, particularly oral tumors. In other aspects, the compounds are administered systemically. Compounds of the disclosure are also useful in the treatment of pain associated with tumors to which the compounds are administered.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112262137-A
priorityDate 2014-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014089067-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102958914-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164153501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467601993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163536059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465120816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466017584

Total number of triples: 38.